No Evidence for Oversizing Hearts and Donor Size Impact on 1-Year Survival in Heart Failure Patients With Left Ventricular Assist Device.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 11 2023
Historique:
received: 14 06 2023
revised: 16 08 2023
accepted: 20 08 2023
medline: 6 11 2023
pubmed: 27 9 2023
entrez: 26 9 2023
Statut: ppublish

Résumé

The predicted heart mass (PHM) ratio has recently emerged as a better metric for donor-to-recipient size-matching than weight ratios. It is unknown whether this applies to transplant candidates on left ventricular assist device (LVAD) support. Our study examines if PHM ratio is optimal for size-matching specifically in the LVAD patient population. Patients with LVAD who received a heart transplant from January 1997 to December 2020 in the Scientific Registry of Transplant Recipients database were studied. We compared 5 size-matching metrics, including donor-recipient ratios of weight, height, body mass index, body surface area, and PHM. Single and multivariable Cox proportional hazards models for 1-year mortality were calculated. Our sample consisted of 11,891 patients. In our multivariate analysis, we found that patients in the undersized group with PHM ratios <0.83 had a hazard ratio for 1-year mortality of 1.34 (95% confidence interval 1.08 to 1.65, p = 0.007) suggestive of increased mortality with the use of undersized donors. There was no statistical difference in mortality between the matched (PHM ratio 0.83 to 1.2) and oversized group (PHM ratio ≥1.2). In heart transplant recipients on LVAD support, the PHM ratio provides better risk stratification than other metrics. Use of undersized donor hearts with PHM ratio <0.83 confers higher 1-year mortality. Using oversized donor hearts for transplantation in recipients on LVAD support has no benefit.

Identifiants

pubmed: 37751669
pii: S0002-9149(23)00884-6
doi: 10.1016/j.amjcard.2023.08.125
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-221

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

Bhavana Siddegowda-Bangalore (B)

Division of Cardiovascular Medicine, Orlando Health Heart & Vascular Institute, Orlando, Florida; Miller College of Business, Ball State University, Muncie, Indiana; Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana.

Srikant Devaraj (S)

Miller College of Business, Ball State University, Muncie, Indiana.

Roopa A Rao (RA)

Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana.

S Hammad Jafri (SH)

Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana. Electronic address: sjafri@iuhealth.org.

Onyedika J Ilonze (OJ)

Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana.

Chadrick E Denlinger (CE)

Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana.

Maya Guglin (M)

Advanced Heart Failure and Transplant Fellowship, Indiana University, Indianapolis, Indiana. Electronic address: mguglin@iu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH